Thomas Steyer’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Thomas Steyer’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,440,000	Closed	-$69.1M	–	137
2020 Q1	$69.1M	Buy	1,440,000 +251,900	+21%	+$11.7M	0.59%	34
2019 Q4	$55.8M	Buy	+1,188,100	New	+$52.5M	0.38%	52

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Thomas Steyer's RARX Position: Q2 2020 in Review

Thomas Steyer sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 1,440,000 shares — an estimated $69.1M sold.

Thomas Steyer first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $69.1M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Thomas Steyer reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Thomas Steyer sold 1,440,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $69.1M.
Thomas Steyer first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Thomas Steyer's Ra Pharmaceuticals, Inc. Common Stock position peaked at $69.1M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Farallon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.